Need help finding what you are looking for?
Contact Us
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1150085
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1150085
Rare Disease Genetic Testing Market Share, Size, Trends, Industry Analysis Report, By Specialty ; By Technology; By Disease Type; By End-Use; By Region; Segment Forecast, 2022 - 2030
PUBLISHED:
PAGES: 119 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global rare disease genetic testing market size is expected to reach USD 2,414.90 million by 2030 according to a new study by Polaris Market Research. The report "Rare Disease Genetic Testing Market Share, Size, Trends, Industry Analysis Report, By Specialty (Molecular Genetic Tests, Chromosomal Genetic Tests, Biochemical Genetic Tests); By Technology; By Disease Type; By End-Use; By Region; Segment Forecast, 2022 - 2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Increasing technological advancements, including NGS and microarray, are prominent factors responsible for the market's growth. Also, the existence of Rare Diseases Clinical Research Network (RDCRN), an NIH-funded research network of 23 active research groups focused on the diagnosis & treatment of disorders, is anticipated to impact the industry positively. Furthermore, the decline in sequencing prices has shifted the attention to testing rare diseases, which has influenced the adoption of NGS, resulting in the market's growth.
Translational research and genomic technologies play a crucial role in accelerating the investigation and identification of new mutations, which aid in market expansion. Due to numerous translational research activities in this field, genetic testing in disease diagnostics is expected to rise rapidly throughout the projection period.
An increase in patient registry for rare diseases and development of new products to treat rare diseases are stimulating the growth of the market. The market is expected to grow as the number and quality of available registries continue to expand. So advanced data collection and interpretation technologies that can be used in clinical practices improve. An increasing number of patients undergoing disease testing, as well as increased government assistance, will fuel several new opportunities for market growth.
Rare Disease Genetic Testing Market Report Highlights
Endocrine and metabolism disease witnessed the largest market share in 2021 due to the growing number of patients with Cushing's syndrome.
The next-generation sequencing segment acquires significant market share due to increasing medical acceptance of whole exome sequencing-based gene tests.
Molecular genetic test segment is anticipated to hold considerable market share during the forecast period due to advanced testing technologies such as genome sequencing, which is affordable.
Research labs & CROs accounted largest market share in 2021 due to a large number of genetic tests performed in research laboratories and CROs.
North America dominated the market in 2021 due to the high prevalence of rare diseases and the abundance of registries in this region.
The global market is highly competitive owing to the existence of large industry players with a global presence of 3billion, Inc., Ambry Genetics, Artemis DNA, Arup Laboratories, Baylor Genetics, Centogene N.V., Color Genomics, Inc., Coopersurgical, Inc., Eurofins Scientific, Fulgent Genetics Inc., Genomenon, Health Network Laboratories, Invitae Corp., Laboratory Corporation of America Holdings, Macrogen, Inc., Myriad Genetics, Inc., Opko Health, Inc., Perkin Elmer, Inc., PreventionGenetics, Progenity, Inc., Quest Diagnostics Inc., Realm IDX, Inc., and Strand Life Sciences.
Polaris Market Research has segmented the rare disease genetic testing market report based on disease type, technology, specialty, end-use, and regions:
Rare Disease Genetic Testing, Disease Type Outlook (Revenue - USD Million, 2018 - 2030)
Neurological disease
Immunological disorders
Hematology diseases
Endocrine and metabolism diseases
Cancer
Musculoskeletal disorders
Cardiovascular disorders
Dermatological disease
Others
Rare Disease Genetic Testing, Technology Outlook (Revenue - USD Million, 2018 - 2030)
Next-generation sequencing
Whole Exome
Whole Genome
Array Technology
PCR-based testing
FISH
Sanger Sequencing
Karyotyping
Rare Disease Genetic Testing, Specialty Outlook (Revenue - USD Million, 2018 - 2030)
Molecular genetic tests
Chromosomal genetic tests
Biochemical genetic tests
Rare Disease Genetic Testing, End-Use Outlook (Revenue - USD Million, 2018 - 2030)
Research Lab and CROs
Hospitals and Clinics
Diagnostic Laboratories
Rare Disease Genetic Testing, Regional Outlook (Revenue - USD Million, 2018 - 2030)
North America
U.S
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Product Code: PM1772
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Rare Disease Genetic Testing Market Insights
- 4.1. Rare Disease Genetic Testing - Industry Snapshot
- 4.2. Rare Disease Genetic Testing Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Expanding patient registry for rare disease
- 4.2.1.2. Government & Regulatory Support For Rare Disease Diagnosis
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Limited Awareness about The Rare Disease Conditions
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Rare Disease Genetic Testing Industry Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Rare Disease Genetic Testing Market, by Technology
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- 5.3. Next-Generation Sequencing
- 5.3.1. Global Rare Disease Genetic Testing Market, by Next-Generation Sequencing, by Region, 2018 - 2030 (USD Million)
- 5.3.2. Whole Exome
- 5.3.2.1. Global Rare Disease Genetic Testing Market, by Whole Exome, by Region, 2018 - 2030 (USD Million)
- 5.3.3. Whole Genome
- 5.3.3.1. Global Rare Disease Genetic Testing Market, by Whole Genome, by Region, 2018 - 2030 (USD Million)
- 5.4. Array Technology
- 5.4.1. Global Rare Disease Genetic Testing Market, by Array Technology, by Region, 2018 - 2030 (USD Million)
- 5.5. PCR-based Testing
- 5.5.1. Global Rare Disease Genetic Testing Market, by PCR-based Testing, by Region, 2018 - 2030 (USD Million)
- 5.6. FISH
- 5.6.1. Global Rare Disease Genetic Testing Market, by FISH, by Region, 2018 - 2030 (USD Million)
- 5.7. Sanger Sequencing
- 5.7.1. Global Rare Disease Genetic Testing Market, by Sanger Sequencing, by Region, 2018 - 2030 (USD Million)
- 5.8. Karyotyping
- 5.8.1. Global Rare Disease Genetic Testing Market, by Karyotyping, by Region, 2018 - 2030 (USD Million)
6. Global Rare Disease Genetic Testing Market, by Specialty
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- 6.3. Molecular Genetic Tests
- 6.3.1. Global Rare Disease Genetic Testing Market, by Molecular Genetic Tests, by Region, 2018 - 2030 (USD Million)
- 6.4. Chromosomal Genetic Tests
- 6.4.1. Global Rare Disease Genetic Testing Market, by Chromosomal Genetic Tests, by Region, 2018 - 2030 (USD Million)
- 6.5. Biochemical, Genetic Tests
- 6.5.1. Global Rare Disease Genetic Testing Market, by Biochemical, Genetic Tests, by Region, 2018 - 2030 (USD Million)
7. Global Rare Disease Genetic Testing Market, by Disease Type
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- 7.3. Neurological Disease
- 7.3.1. Global Rare Disease Genetic Testing Market, by Neurological Disease, by Region, 2018 - 2030 (USD Million)
- 7.4. Immunological Disorders
- 7.4.1. Global Rare Disease Genetic Testing Market, by Immunological Disorders, by Region, 2018 - 2030 (USD Million)
- 7.5. Hematology Diseases
- 7.5.1. Global Rare Disease Genetic Testing Market, by Hematology Diseases, by Region, 2018 - 2030 (USD Million)
- 7.6. Endocrine & Metabolism Diseases
- 7.6.1. Global Rare Disease Genetic Testing Market, by Endocrine & Metabolism Diseases, by Region, 2018 - 2030 (USD Million)
- 7.7. Cancer
- 7.7.1. Global Rare Disease Genetic Testing Market, by Cancer, by Region, 2018 - 2030 (USD Million)
- 7.8. Musculoskeletal Disorders
- 7.8.1. Global Rare Disease Genetic Testing Market, by Musculoskeletal Disorders, by Region, 2018 - 2030 (USD Million)
- 7.9. Cardiovascular Disorders
- 7.9.1. Global Rare Disease Genetic Testing Market, by Cardiovascular Disorders, by Region, 2018 - 2030 (USD Million)
- 7.10. Dermatology Disease
- 7.10.1. Global Rare Disease Genetic Testing Market, by Dermatology Disease, by Region, 2018 - 2030 (USD Million)
- 7.11. Others
- 7.11.1. Global Other Rare Disease Genetic Testing Market, by Region, 2018 - 2030 (USD Million)
8. Global Rare Disease Genetic Testing Market, by End-use
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- 8.3. Research Laboratories & Cros
- 8.3.1. Global Rare Disease Genetic Testing Market, by Research Laboratories & Cros, by Region, 2018 - 2030 (USD Million)
- 8.4. Hospitals & Clinics
- 8.4.1. Global Rare Disease Genetic Testing Market, by Hospitals & Clinics, by Region, 2018 - 2030 (USD Million)
- 8.5. Diagnostic Laboratories
- 8.5.1. Global Rare Disease Genetic Testing Market, by Diagnostic Laboratories, by Region, 2018 - 2030 (USD Million)
9. Global Rare Disease Genetic Testing Market, by Geography
- 9.1. Key findings
- 9.2. Introduction
- 9.2.1. Rare Disease Genetic Testing Market Assessment, By Geography, 2018 - 2030 (USD Million)
- 9.3. Rare Disease Genetic Testing Market - North America
- 9.3.1. North America: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- 9.3.2. North America: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- 9.3.3. North America: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- 9.3.4. North America: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- 9.3.5. Rare Disease Genetic Testing Market - U.S.
- 9.3.5.1. U.S.: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- 9.3.5.2. U.S.: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- 9.3.5.3. U.S.: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- 9.3.5.4. U.S.: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- 9.3.6. Rare Disease Genetic Testing Market - Canada
- 9.3.6.1. Canada: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- 9.3.6.2. Canada: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- 9.3.6.3. Canada: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- 9.3.6.4. Canada: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- 9.4. Rare Disease Genetic Testing Market - Europe
- 9.4.1. Europe: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- 9.4.2. Europe: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- 9.4.3. Europe: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- 9.4.4. Europe: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- 9.4.5. Rare Disease Genetic Testing Market - UK
- 9.4.5.1. UK: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- 9.4.5.2. UK: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- 9.4.5.3. UK: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- 9.4.5.4. UK: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- 9.4.6. Rare Disease Genetic Testing Market - France
- 9.4.6.1. France: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- 9.4.6.2. France: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- 9.4.6.3. France: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- 9.4.6.4. France: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- 9.4.7. Rare Disease Genetic Testing Market - Germany
- 9.4.7.1. Germany: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- 9.4.7.2. Germany: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- 9.4.7.3. Germany: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- 9.4.7.4. Germany: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- 9.4.8. Rare Disease Genetic Testing Market - Italy
- 9.4.8.1. Italy: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- 9.4.8.2. Italy: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- 9.4.8.3. Italy: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- 9.4.8.4. Italy: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- 9.4.9. Rare Disease Genetic Testing Market - Spain
- 9.4.9.1. Spain: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- 9.4.9.2. Spain: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- 9.4.9.3. Spain: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- 9.4.9.4. Spain: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- 9.4.10. Rare Disease Genetic Testing Market - Netherlands
- 9.4.10.1. Netherlands: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- 9.4.10.2. Netherlands: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- 9.4.10.3. Netherlands: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- 9.4.10.4. Netherlands: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- 9.4.11. Rare Disease Genetic Testing Market - Russia
- 9.4.11.1. Russia: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- 9.4.11.2. Russia.: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- 9.4.11.3. Russia: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- 9.4.11.4. Russia: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- 9.5. Rare Disease Genetic Testing Market - Asia Pacific
- 9.5.1. Asia Pacific: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- 9.5.2. Asia Pacific: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- 9.5.3. Asia Pacific: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- 9.5.4. Asia Pacific: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- 9.5.5. Rare Disease Genetic Testing Market - China
- 9.5.5.1. China: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- 9.5.5.2. China.: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- 9.5.5.3. China: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- 9.5.5.4. China: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- 9.5.6. Rare Disease Genetic Testing Market - India
- 9.5.6.1. India: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- 9.5.6.2. India.: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- 9.5.6.3. India: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- 9.5.6.4. India: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- 9.5.7. Rare Disease Genetic Testing Market - Japan
- 9.5.7.1. Japan: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- 9.5.7.2. Japan.: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- 9.5.7.3. Japan: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- 9.5.7.4. Japan: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- 9.5.8. Rare Disease Genetic Testing Market - Malaysia
- 9.5.8.1. Malaysia: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- 9.5.8.2. Malaysia.: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- 9.5.8.3. Malaysia: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- 9.5.8.4. Malaysia: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- 9.5.9. Rare Disease Genetic Testing Market - Indonesia
- 9.5.9.1. Indonesia: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- 9.5.9.2. Indonesia.: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- 9.5.9.3. Indonesia: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- 9.5.9.4. Indonesia: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- 9.5.10. Rare Disease Genetic Testing Market - South Korea
- 9.5.10.1. South Korea: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- 9.5.10.2. South Korea.: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- 9.5.10.3. South Korea: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- 9.5.10.4. South Korea: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- 9.6. Rare Disease Genetic Testing Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- 9.6.2. Middle East & Africa: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- 9.6.3. Middle East & Africa: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- 9.6.4. Middle East & Africa: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- 9.6.5. Rare Disease Genetic Testing Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- 9.6.5.2. Saudi Arabia: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- 9.6.5.3. Saudi Arabia: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- 9.6.5.4. Saudi Arabia: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- 9.6.6. Rare Disease Genetic Testing Market - South Africa
- 9.6.6.1. South Africa: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- 9.6.6.2. South Africa: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- 9.6.6.3. South Africa: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- 9.6.6.4. South Africa: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- 9.6.7. Rare Disease Genetic Testing Market - Israel
- 9.6.7.1. Israel: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- 9.6.7.2. Israel: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- 9.6.7.3. Israel: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- 9.6.7.4. Israel: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- 9.6.8. Rare Disease Genetic Testing Market - UAE
- 9.6.8.1. UAE: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- 9.6.8.2. UAE: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- 9.6.8.3. UAE: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- 9.6.8.4. UAE: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- 9.7. Rare Disease Genetic Testing Market - Latin America
- 9.7.1. Latin America: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- 9.7.2. Latin America: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- 9.7.3. Latin America: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- 9.7.4. Latin America: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- 9.7.5. Rare Disease Genetic Testing Market - Mexico
- 9.7.5.1. Mexico: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- 9.7.5.2. Mexico: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- 9.7.5.3. Mexico: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- 9.7.5.4. Mexico: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- 9.7.6. Rare Disease Genetic Testing Market - Brazil
- 9.7.6.1. Brazil: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- 9.7.6.2. Brazil: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- 9.7.6.3. Brazil: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- 9.7.6.4. Brazil: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- 9.7.7. Rare Disease Genetic Testing Market - Argentina
- 9.7.7.1. Argentina: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- 9.7.7.2. Argentina: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- 9.7.7.3. Argentina: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- 9.7.7.4. Argentina: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. 3billion, Inc
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Ambry Genetics
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Artemis DNA
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. Arup Laboratories
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. Baylor Genetics
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. Centogene N.V
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Color Genomics, Inc
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Coopersurgical, Inc
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. Eurofins Scientific
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. Fulgent Genetics Inc
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
- 11.11. Genomenon
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
- 11.12. Health Network Laboratories
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
- 11.13. Invitae Corp
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
- 11.14. Laboratory Corporation of America Holdings
- 11.14.1. Company Overview
- 11.14.2. Financial Performance
- 11.14.3. Product Benchmarking
- 11.14.4. Recent Development
- 11.15. Macrogen, Inc
- 11.15.1. Company Overview
- 11.15.2. Financial Performance
- 11.15.3. Product Benchmarking
- 11.15.4. Recent Development
- 11.16. Myriad Genetics, Inc.
- 11.16.1. Company Overview
- 11.16.2. Financial Performance
- 11.16.3. Product Benchmarking
- 11.16.4. Recent Development
- 11.17. Opko Health, Inc
- 11.17.1. Company Overview
- 11.17.2. Financial Performance
- 11.17.3. Product Benchmarking
- 11.17.4. Recent Development
- 11.18. Perkin Elmer, Inc
- 11.18.1. Company Overview
- 11.18.2. Financial Performance
- 11.18.3. Product Benchmarking
- 11.18.4. Recent Development
- 11.19. PreventionGenetics
- 11.19.1. Company Overview
- 11.19.2. Financial Performance
- 11.19.3. Product Benchmarking
- 11.19.4. Recent Development
- 11.20. Progenity, Inc
- 11.20.1. Company Overview
- 11.20.2. Financial Performance
- 11.20.3. Product Benchmarking
- 11.20.4. Recent Development
- 11.21. Quest Diagnostics Inc.
- 11.21.1. Company Overview
- 11.21.2. Financial Performance
- 11.21.3. Product Benchmarking
- 11.21.4. Recent Development
- 11.22. Realm IDX, Inc
- 11.22.1. Company Overview
- 11.22.2. Financial Performance
- 11.22.3. Product Benchmarking
- 11.22.4. Recent Development
- 11.23. Strand Life Sciences.
- 11.23.1. Company Overview
- 11.23.2. Financial Performance
- 11.23.3. Product Benchmarking
- 11.23.4. Recent Development
Product Code: PM1772
List of Tables
- Table 1 Global Rare Disease Genetic Testing Market, by Technology, by Region, 2018 - 2030 (USD Million)
- Table 2 Global Rare Disease Genetic Testing Market, by Specialty, by Region, 2018 - 2030 (USD Million)
- Table 3 Global Rare Disease Genetic Testing Market, by Disease Type, by Region, 2018 - 2030 (USD Million)
- Table 4 Global Rare Disease Genetic Testing Market, by End-use, by Region, 2018 - 2030 (USD Million)
- Table 5 Rare Disease Genetic Testing Market Assessment, By Geography, 2018 - 2030 (USD Million)
- Table 6 North America: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- Table 7 North America: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- Table 8 North America: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 9 North America: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- Table 10 U.S.: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- Table 11 U.S.: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- Table 12 U.S.: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 13 U.S.: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- Table 14 Canada: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- Table 15 Canada: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- Table 16 Canada: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 17 Canada: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- Table 18 Europe: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- Table 19 Europe: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- Table 20 Europe: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 21 Europe: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- Table 22 Germany: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- Table 23 Germany: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- Table 24 Germany: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 25 Germany: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- Table 26 France: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- Table 27 France: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- Table 28 France: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 29 France: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- Table 30 UK: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- Table 31 UK: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- Table 32 UK: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 33 UK: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- Table 34 Italy: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- Table 35 Italy: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- Table 36 Italy: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 37 Italy: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- Table 38 Netherlands: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- Table 39 Netherlands: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- Table 40 Netherlands: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 41 Netherlands: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- Table 42 Spain: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- Table 43 Spain: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- Table 44 Spain: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 45 Spain: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- Table 46 Russia: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- Table 47 Russia: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- Table 48 Russia: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 49 Russia: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- Table 50 Asia Pacific: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- Table 51 Asia Pacific: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- Table 52 Asia Pacific: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 53 Asia Pacific: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- Table 54 China: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- Table 55 China: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- Table 56 China: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 57 China: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- Table 58 Japan: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- Table 59 Japan: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- Table 60 Japan: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 61 Japan: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- Table 62 India: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- Table 63 India: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- Table 64 India: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 65 India: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- Table 66 Indonesia: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- Table 67 Indonesia: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- Table 68 Indonesia: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 69 Indonesia: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- Table 70 Malaysia: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- Table 71 Malaysia: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- Table 72 Malaysia: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 73 Malaysia: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- Table 74 South Korea: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- Table 75 South Korea: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- Table 76 South Korea: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 77 South Korea: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- Table 78 Latin America: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- Table 79 Latin America: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- Table 80 Latin America: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 81 Latin America: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- Table 82 Brazil: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- Table 83 Brazil: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- Table 84 Brazil: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 85 Brazil: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- Table 86 Mexico: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- Table 87 Mexico: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- Table 88 Mexico: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 89 Mexico: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- Table 90 Argentina: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- Table 91 Argentina: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- Table 92 Argentina: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 93 Argentina: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- Table 94 Middle East & Africa: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- Table 95 Middle East & Africa: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- Table 96 Middle East & Africa: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 97 Middle East & Africa: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- Table 98 UAE: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- Table 99 UAE: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- Table 100 UAE: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 101 UAE: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- Table 102 Saudi Arabia: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- Table 103 Saudi Arabia: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- Table 104 Saudi Arabia: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 105 Saudi Arabia: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- Table 106 South Africa: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- Table 107 South Africa: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- Table 108 South Africa: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 109 South Africa: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
- Table 110 Israel: Rare Disease Genetic Testing Market, by Technology, 2018 - 2030 (USD Million)
- Table 111 Israel: Rare Disease Genetic Testing Market, by Specialty, 2018 - 2030 (USD Million)
- Table 112 Israel: Rare Disease Genetic Testing Market, by Disease Type, 2018 - 2030 (USD Million)
- Table 113 Israel: Rare Disease Genetic Testing Market, by End-use, 2018 - 2030 (USD Million)
List of Figures
Figure 1. Global Rare Disease Genetic Testing Market, 2018 - 2030 (USD Million)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up End-use
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Technology
Figure 7. Global Rare Disease Genetic Testing Market, by Technology, 2021 & 2030 (USD Million)
Figure 8. Market by End-use
Figure 9. Global Rare Disease Genetic Testing Market, by End-use, 2021 & 2030 (USD Million)
Figure 10. Market by Specialty
Figure 11. Global Rare Disease Genetic Testing Market, by Specialty, 2021 & 2030 (USD Million)
Figure 12. Market by Disease Type
Figure 13. Global Rare Disease Genetic Testing Market, by Disease Type, 2021 & 2030 (USD Million)
Figure 14. Rare Disease Genetic Testing Market Assessment, By Geography, 2018 - 2030 (USD Million)
Figure 15. Strategic Analysis - Rare Disease Genetic Testing Market
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.